附录

Author guidelines: Volume 5 Issue 5

• 抽象的

附录

Acknowledgment: Volume 5 Issue 5

• 抽象的

附录

Indices: Volume 5 Issue 5

• 抽象的

附录

Glossary: Volume 5 Issue 5

• 抽象的

看法

HIV drug policies and South markets: settling controversies

Daniele Dionisio, Claudio Fabbri and Daniela Messeri

• 抽象的

研究文章

Study of the extraction, purification and antidiabetic potential of ursolic acid from Cornus officinalis Sieb. et Zucc.

Dawei Gao, Na Li, Qingwang Li, Jian Li, Zengsheng Han, Yusheng Fan and Zhiwei Liu

• 抽象的

评论文章

Management of pediatric multiple sclerosis

Lauren B Krupp

• 抽象的

评论文章

Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis

Meghann Teague Getts, Daniel R Getts, Adam P Kohm and Stephen D Miller

• 抽象的

评论文章

Pharmacogenomics in multiple sclerosis: getting the right medicine to the right patient

Manuel Comabella

• 抽象的

评论文章

Novel designs for clinical trials in multiple sclerosis: another excursion to Sirenum scopuli?

Stacey S Cofield and Gary R Cutter

• 抽象的

药物评价

Dirucotide (MBP8298) for the treatment of multiple sclerosis

Clyde Markowitz

• 抽象的

药物评价

Dabigatran etexilate: an oral direct thrombin inhibitor

Ola E Dahl

• 抽象的

药物评价

Desmopressin for the treatment of adult nocturia

Hashim Hashim and Paul Abrams

• 抽象的

优先论文评估

Efficacy of tocilizumab, a humanized anti-IL-6 receptor antibody, in rheumatoid arthritis

Yoshiyuki Ohsugi

• 抽象的

附录

Bulletin Board: Volume 5 Issue 5

• 抽象的

社论

What is the optimal vitamin D level for health?

Edward Giovannucci

• 抽象的

研究亮点

Highlights from the latest articles in multiple sclerosis

• 抽象的

面试

Dr Leslie Weiner speaks to Charlotte Barker, Commissioning Editor

Leslie P Weiner

• 抽象的

新闻与观点

Multiple sclerosis therapeutics

• 抽象的

社论

What are new therapies teaching us about the immunology of multiple sclerosis?

Michael K Racke and Amy E Lovett-Racke

• 抽象的

前言

Multiple sclerosis therapeutics: opportunities, strategies and challenges

Richard A Rudick

• 抽象的